AzTrials
AzTrials

Sleep Apnea (Disorder)NCT05272449

Evaluation of a Disposable Sound Sensor for Recording Respiration During Sleep

A study testing Sleep apnea diagnosis in people with Sleep Apnea (Disorder), run by CIDELEC.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Split-night prospective monocentric study to evaluate, in real conditions, the effectiveness of a disposable tracheal sound sensor. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sleep Apnea (Disorder)
What is being tested?
Sleep apnea diagnosis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
28 Feb 2022to 28 Apr 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with suspected obstructive sleep apnea

Who cannot join

  • Lung infection
  • Insomnia

About this study

Split-night prospective monocentric study to evaluate, in real conditions, the effectiveness of a disposable tracheal sound sensor.

Being tested
Sleep apnea diagnosis
Medical subject headings
Sleep Apnea Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sleep apnea diagnosisDevice

    Split-night

Study groups in NCT05272449
Study groupRoleWhat they receive
Evaluation of a disposable sound sensor for recording respiration during sleepExperimentalPneaVoX sensor, CIDELEC
Receives: Device: Sleep apnea diagnosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Analyzable signal time

    Percentage of the analyzable signal duration compared to the total recorded signal duration

    Measured: One night

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Mar 2022
  2. Study start28 Feb 2022 (estimated)
  3. Primary completion28 Apr 2022 (estimated)
  4. Study completion28 Apr 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05272449
Sponsor's protocol ID
2021-A02524-37
Status last verified
Feb 2022
First submitted
17 Feb 2022
Last updated
9 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Sleep apnea diagnosis in people with Sleep Apnea (Disorder), run by CIDELEC.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Analyzable signal time (time frame: One night). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in